Statins, including Pfizer Inc.’s Lipitor, are among the most prescribed drug in the world, and are currently routinely taken by millions of Americans. They are indicated for people with high blood pressure and/or high cholesterol, and have been shown to significantly reduce the risk of heart disease, heart attack, and stroke in this population. Yet the FDA has just issued new warnings concerning potential side effects: elevated blood sugar, which is a risk factor for developing type 2 diabetes, and cognitive impairment such as memory loss. The warnings will not be affixed to the outside of the bottle, but will be included in the package insert that comes with all prescription medications.

A new strategic plan to guide diabetes-related research over the next decade was announced recently by the National Institutes of Health. The plan, developed by a federal work group led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), identifies research opportunities with the greatest potential to benefit the millions of Americans who are living with or at risk for diabetes and its complications.

In the United States, 23.6 million children and adults — 7.8% of the population — have diabetes and one-third of U.S. adults are obese [1-2]. Obesity is associated with an increased risk of developing type 2 diabetes as well as insulin resistance, a condition that precedes the development of type 2 diabetes. New research published in the Journal of Nutrition now suggests that blueberries can help improve insulin sensitivity in obese, non-diabetic and insulin-resistant people [3].